Search research articles
Contact Us
Filters
Showing results (911-920 of 996) with videos related to
Page
of 100
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 17, 2018
Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular study
Deepika Sirohi, Charlie Vaske, Zack Sanborn, et al.
Nature
|
August 7, 2015
Structural insights into µ-opioid receptor activation
Weijiao Huang, Aashish Manglik, A J Venkatakrishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2016
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
Christophe Massard, Michael S Gordon, Sunil Sharma, et al.
Nature
|
July 30, 2020
Author Correction: Structural insights into μ-opioid receptor activation
Weijiao Huang, Aashish Manglik, A J Venkatakrishnan, et al.
The American Journal of Cardiology
|
December 31, 1997
Excimer laser coronary angioplasty: the New Approaches to Coronary Intervention (NACI) experience
D R Holmes, S Mehta, C J George, et al.
JAMA
|
February 15, 2001
One-year survival following early revascularization for cardiogenic shock
J S Hochman, L A Sleeper, H D White, et al.
Nature Cancer
|
May 26, 2025
Skeletal muscle endothelial dysfunction through the activin A-PGC1α axis drives progression of cancer cachexia
Young-Mee Kim, Mark A Sanborn, Shaluah Vijeth, et al.
The American Journal of Sports Medicine
|
January 16, 2023
Quantitative MRI Biomarkers to Predict Risk of Reinjury Within 2 Years After Bridge-Enhanced ACL Restoration
Dominique A Barnes, Gary J Badger, Yi-Meng Yen, et al.
The American Journal of Sports Medicine
|
November 22, 2022
Preoperative Risk Factors for Subsequent Ipsilateral ACL Revision Surgery After an ACL Restoration Procedure
Ryan M Sanborn, Gary J Badger, Braden C Fleming, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2018
Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study
Leora Horn, Jeffrey R Infante, Karen L Reckamp, et al.
Page
of 100
Search research articles
Search
Showing results (911-920 of 996) with videos related to
Sort By:
Page
of 100
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 17, 2018
Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular study
Deepika Sirohi, Charlie Vaske, Zack Sanborn, et al.
Nature
|
August 7, 2015
Structural insights into µ-opioid receptor activation
Weijiao Huang, Aashish Manglik, A J Venkatakrishnan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2016
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
Christophe Massard, Michael S Gordon, Sunil Sharma, et al.
Nature
|
July 30, 2020
Author Correction: Structural insights into μ-opioid receptor activation
Weijiao Huang, Aashish Manglik, A J Venkatakrishnan, et al.
The American Journal of Cardiology
|
December 31, 1997
Excimer laser coronary angioplasty: the New Approaches to Coronary Intervention (NACI) experience
D R Holmes, S Mehta, C J George, et al.
JAMA
|
February 15, 2001
One-year survival following early revascularization for cardiogenic shock
J S Hochman, L A Sleeper, H D White, et al.
Nature Cancer
|
May 26, 2025
Skeletal muscle endothelial dysfunction through the activin A-PGC1α axis drives progression of cancer cachexia
Young-Mee Kim, Mark A Sanborn, Shaluah Vijeth, et al.
The American Journal of Sports Medicine
|
January 16, 2023
Quantitative MRI Biomarkers to Predict Risk of Reinjury Within 2 Years After Bridge-Enhanced ACL Restoration
Dominique A Barnes, Gary J Badger, Yi-Meng Yen, et al.
The American Journal of Sports Medicine
|
November 22, 2022
Preoperative Risk Factors for Subsequent Ipsilateral ACL Revision Surgery After an ACL Restoration Procedure
Ryan M Sanborn, Gary J Badger, Braden C Fleming, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 23, 2018
Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study
Leora Horn, Jeffrey R Infante, Karen L Reckamp, et al.
Page
of 100